Medication Available for Adults with Sickle Cell Disease Through Clinical Trial at Memorial

Memorial Healthcare System is participating in a multi-center clinical research study evaluating an investigational medication for adults living with sickle cell disease.

The study is being conducted at Memorial’s Sickle Cell Medical Home in Hollywood, which is currently the only participating site in Florida. The investigational medication is being evaluated as part of a Phase III clinical trial sponsored externally. The purpose of the study is to further assess the safety and potential clinical effects of the medication in adults with sickle cell disease.

Sickle cell disease is an inherited blood disorder that affects red blood cells, leading to chronic health complications, including anemia, pain episodes, and increased risk of infection. Clinical research studies are an important part of advancing potential future treatment options for individuals living with this condition.

“Our facility provides sickle cell patients a medical home, one that features the resources of a day hospital, primary care, hematology, pharmacy, and social services at one location,” said Foluso “Joy” Ogunsile, MD, a hematologist and director at the sickle cell medical home. “We’re uniquely qualified to offer this novel study as we work to stop the cycle of blood cell breakdown and pain.”

Participation in clinical research is voluntary and subject to specific eligibility criteria. Individuals interested in learning more about clinical research opportunities at Memorial should speak with their healthcare provider or contact the Memorial Sickle Cell Medical Home for general information.

The sickle cell medical home is unique to South Florida and is designed with resources to serve sickle cell warriors. Located at 3700 Johnson Street in Hollywood, the facility was opened in 2022 after a contribution from the nonprofit Memorial Foundation made it possible to relocate, enhance, and expand services to the community.